Community case management of chest indrawing pneumonia in children aged 2 to 59 months by community health workers: study protocol for a multi-country cluster randomized open label non-inferiority trial

Authors

  • Yasir Bin Nisar Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Avenue Appia 20, Geneva, Switzerland

DOI:

https://doi.org/10.18203/2349-3259.ijct20201719

Keywords:

Children under five years of age, Chest indrawing pneumonia, Enhanced community case management, iCCM, Community level health worker, Amoxicillin, Pulse oximeter

Abstract

Background: The World Health Organization (WHO) integrated management of childhood illness (IMCI) protocol recommends treatment of chest indrawing in 2-59 months old children with oral amoxicillin by trained health facility workers. Whereas, the WHO/UNICEF integrated community case management (iCCM) protocol recommends referral by community level health workers (CLHWs) to a health facility. This study aims to evaluate whether CLHWs can treat chest indrawing pneumonia effectively and safely.

Methods: This multi-centre cluster randomized controlled open label, non-inferiority trial will be conducted in Bangladesh, Ethiopia, India and Malawi. All sites will use a common protocol with the same study design, participants, intervention, control and outcomes. CLHWs will identify 2-59 months old children with chest indrawing. Study supervisors, trained in the iCCM protocol, will confirm CLHWs’ findings. Pulse oximetry will be used to identify hypoxaemic children. In the intervention group, enrolled children will be treated with oral amoxicillin for 5 days, and in the control group they will be referred to a health facility, after providing first dose of oral amoxicillin. An independent outcome assessor will visit each enrolled child on days 6 and 14 of enrolment, to assess study outcomes.

Conclusions: If CLHWs can effectively and safely treat chest indrawing pneumonia in 2-59 months old children, it will increase access to pneumonia treatment substantially, as in many settings, health facilities and trained health workers are not easily accessible. Moreover, this evidence will contribute towards the review of the current iCCM protocol and its harmonization with the IMCI protocol.

Trial Registration: The trial is registered at AZNCTR International Trial Registry as ACTRN12617000857303.

Author Biography

Yasir Bin Nisar, Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Avenue Appia 20, Geneva, Switzerland

Medical officer, Research and Development

References

Collaborators GBDLRI. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2020;20(1):60-79.

Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012;379(9832):2151-61.

Nair H, Simoes EA, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang JSF, et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet. 2013;381(9875):1380-90.

McAllister DA, Liu L, Shi T, Chu Y, Reed C, Burrows J, et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. 2019;7(1):47-57.

World Health Organization, UNICEF. Ending preventable child deaths from pneumonia and diarrhoea by 2025: The integrated Global Action Plan for Pneumonia and Diarrhoea France: WHO and UNICEF, 2013.

Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352(1):39-47.

Qazi SA, Rehman GN, Khan MA. Standard management of acute respiratory infections in a children's hospital in Pakistan: impact on antibiotic use and case fatality. Bull World Health Organ. 1996;74(5):501-7.

Bari A, Sadruddin S, Khan A, Khan I, Khan A, Lehri IA, et al. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial. Lancet. 2011;378(9805):1796-803.

World Health Organization, UNICEF. WHO/UNICEF Joint Statement: Integrated Community Case Management (iCCM). Switzerland: WHO & UNICEF, 2012.

Sutrisna B, Reingold A, Kresno S, Harrison G, Utomo B. Care-seeking for fatal illnesses in young children in Indramayu, west Java, Indonesia. Lancet. 1993;342(8874):787-9.

Kallander K, Hildenwall H, Waiswa P, Galiwango E, Peterson S, Pariyo G. Delayed care seeking for fatal pneumonia in children aged under five years in Uganda: a case-series study. Bull World Health Organ. 2008;86(5):332-8.

Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group. Lancet. 1998;352(9124):270-4.

Addo-Yobo E, Chisaka N, Hassan M, Hibberd P, Lozano JM, Jeena P, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet. 2004;364(9440):1141-8.

Hazir T, Fox LM, Nisar YB, Fox MP, Ashraf YP, MacLeod WB, et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet. 2008;371(9606):49-56.

Agweyu A, Gathara D, Oliwa J, Muinga N, Edwards T, Allen E, et al. Oral amoxicillin versus benzyl penicillin for severe pneumonia among kenyan children: a pragmatic randomized controlled noninferiority trial. Clin Infect Dis. 2015;60(8):1216-24.

Patel AB, Bang A, Singh M, Dhande L, Chelliah LR, Malik A, et al. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study. BMC Pediatr. 2015;15:186.

World Health Organization. Revised WHO classification and treatment of childhood pneumonia at health facilities: Evidence summaries. Switzerland: WHO, 2014.

World Health Organization. Integrated Management of Childhood Illness (IMCI): Chart Booklet. Geneva, Switzerland: WHO, 2014.

EMPIC study group. Management of fast breathing pneumonia in young infants aged 7 to 59 days by community level health workers: Protocol for a multi-centre cluster randomized controlled trial. Int J Clin Trials. 2020. (In press)

Subhi R, Adamson M, Campbell H, Weber M, Smith K, Duke T. The prevalence of hypoxaemia among ill children in developing countries: a systematic review. Lancet Infect Dis. 2009;9(4):219-27.

Lazzerini M, Sonego M, Pellegrin MC. Hypoxaemia as a Mortality Risk Factor in Acute Lower Respiratory Infections in Children in Low and Middle-Income Countries: Systematic Review and Meta-Analysis. PLoS One. 2015;10(9):e0136166.

Duke T, Mgone J, Frank D. Hypoxaemia in children with severe pneumonia in Papua New Guinea. Int J Tuberc Lung Dis. 2001;5(6):511-9.

World Health Organization. WHO Model List of Essential Medicines. Geneva, Switzerland: WHO, 2009.

World Health Organization. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses. Switzerland: WHO, 2013.

English M, Esamai F, Wasunna A, Were F, Ogutu B, Wamae A, et al. Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya. Lancet. 2004;363(9425):1948-53.

Graham H, Tosif S, Gray A, Qazi S, Campbell H, Peel D, et al. Providing oxygen to children in hospitals: a realist review. Bull World Health Organ. 2017;95(4):288-302.

World Health Organization, UNICEF. Caring for the sick child in the community. Geneva, Switzerland: WHO. Available at: https://www. who.int/maternal_child_adolescent/documents/caring-for-the-sick-child/en/). Accessed on 3 October 2019.

Wandeler G, Pauchard JY, Zangger E, Diawara H, Gehri M. Which clinical signs predict hypoxaemia in young Senegalese children with acute lower respiratory tract disease? Paediatr Int Child Health. 2015;35(1):65-8.

Basnet S, Adhikari RK, Gurung CK. Hypoxemia in children with pneumonia and its clinical predictors. Indian J Pediatr. 2006;73(9):777-81.

Lodha R, Bhadauria PS, Kuttikat AV, Puranik M, Gupta S, Pandey RM, et al. Can clinical symptoms or signs accurately predict hypoxemia in children with acute lower respiratory tract infections? Indian Pediatr. 2004;41(2):129-35.

Weber MW, Usen S, Palmer A, Jaffar S, Mulholland EK. Predictors of hypoxaemia in hospital admissions with acute lower respiratory tract infection in a developing country. Archives of disease in childhood. 1997;76(4):310-4.

Usen S, Weber M, Mulholland K, Jaffar S, Oparaugo A, Omosigho C, et al. Clinical predictors of hypoxaemia in Gambian children with acute lower respiratory tract infection: prospective cohort study. Clin Res Ed. 1999;318(7176):86-91.

Ministry of Health and Family Welfare, Government of India. ASHA training module Government of India, 2019.

Downloads

Published

2020-04-22